A Comparative Study of Incentive Spirometer Versus Inspiratory Muscle Trainer on Pulmonary Function in Patients With Parkinsonism
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- King Saud University
- Enrollment
- 18
- Locations
- 2
- Primary Endpoint
- Maximum inspiratory pressure (MIP)
Study Overview
Brief Summary
Patients suffering from parkinsonism have respiratory function abnormalities. This study compared the effects of incentive spirometer and inspiratory muscle trainer on pulmonary functions in patients with parkinsonism.
Detailed Description
The participants were recruited according to the inclusion and exclusion criteria. Participants were divided into two groups - incentive spirometer and inspiratory muscle trainer. These trainings were performed for 6 weeks duration. Several outcome measures related to pulmonary function tests were measured before and after the intervention.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Double (Participant, Outcomes Assessor)
Eligibility Criteria
- Ages
- 65 Years to 75 Years (Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients diagnosed as having Parkinsonism Disease by the Neuro physician.
- •Duration of Parkinson's Disease ≥ 5 years.
- •Patients with the age of 65 to 80 years.
- •Hoen and Yahr classification within 1 to
- •Both males and females were included.
- •Patients who were able to comprehend the commands.
- •Patients who were willing to participate.
Exclusion Criteria
- •Patients having any cardiovascular and pulmonary disorders.
- •History of smoking currently or in the past.
- •Psychological Impairment.
- •Insufficient verbal/intellectual understanding.
- •Patients with unstable vital parameters.
- •Those unable to perform pulmonary function tests (PFT) because of anatomical abnormalities or clinical signs of dementia.
Outcomes
Primary Outcomes
Maximum inspiratory pressure (MIP)
Time Frame: 6 weeks
Maximum inspiratory pressure was measured.
Forced vital capacity (FVC)
Time Frame: 6 weeks
Forced vital capacity was measured.
6-minute walk distance (6 MWD)
Time Frame: 6 weeks
Distance walked by the patients in 6 minutes was measured.
Forced expiratory volume in 1 second (FEV1)
Time Frame: 6 weeks
Forced expiratory volume in 1 second was measured
Peak Expiratory Flow Rate (PEFR)
Time Frame: 6 weeks
Peak Expiratory Flow Rate was measured
Secondary Outcomes
No secondary outcomes reported
Investigators
Masood Khan
Researcher
King Saud University
